All data are based on the daily closing price as of April 3, 2026
g

Grape King Bio

1707.TW
3.77 USD
-0.06
-1.57%

Overview

Last close
3.77 usd
Market cap
558.09M usd
52 week high
4.87 usd
52 week low
3.71 usd
Target price
4.32 usd

Valuation

P/E
14.7491
Forward P/E
17.3611
Price/Sales
1.7412
Price/Book Value
1.7547
Enterprise Value
440.41M usd
EV/Revenue
1.3739
EV/EBITDA
4.9263

Key financials

Revenue TTM
320.56M usd
Gross Profit TTM
240.68M usd
EBITDA TTM
81.23M usd
Earnings per Share
0.26 usd
Dividend
N/A usd
Total assets
501.40M usd
Net debt
-125.83M usd

About

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; and microbial fermentation for mushroom mycelium, probiotics, and enzymes. It also offers functional ingredients for intestinal care, immunity regulation, liver care, brain health, eye care, weight control, feminine health, sensual health care, and others. It serves pharmaceutical preparations, finished drugs, oral liquids, and beverages and health foods. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.
  • Symbol
    1707.TW
  • Exchange
    TW
  • Isin
    TW0001707008
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Bing-Jyun Cuei
  • Headquarter
    Taoyuan City
  • Web site
    https://www.grapeking.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top